﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Silicon Investor - Biotech &amp; Pharma.T.A,</title><copyright>Copyright © 2013 Knight Sac Media.  All rights reserved.</copyright><link>http://www.siliconinvestor.com/subject.aspx?subjectid=53258</link><description>The purpose of this thread is to look at Biotechs &amp; Pharma Companies from a T.A. stand point and try to find any recent news that may have triggered the change.  Emphasis to be made on stocks that are on new UP-TRENDS or DOWN-TRENDS.  Feel free to post.  Any opinions and findings concerning any of t...</description><image><url>http://www.siliconinvestor.com/images/Logo380x132.png</url><title>SI - Biotech &amp; Pharma.T.A,</title><link>http://www.siliconinvestor.com/subject.aspx?subjectid=53258</link><width>380</width><height>132</height></image><ttl>10</ttl><item><title>[Jibacoa] It seems that ALIM wants to continue its up-trend without closing its Feb28 UG.&lt;...</title><author>Jibacoa</author><description>It seems that ALIM wants to continue its up-trend without closing its Feb28 UG.&lt;g&gt; bigcharts.marketwatch.com   The CEO is scheduled to present at the Cowen Healthcare Conf, in Boston tomorrow. The ACTAY is $6.25 which could be doable  in spite of the general market. &lt;g&gt; bigcharts.marketwatch.com   Bernard</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27993031</link><pubDate>3/6/2012 11:25:21 AM</pubDate></item><item><title>[Jibacoa] PCYC has continued its up-trend. It is up only about 7% &lt;g&gt; But making another 5...</title><author>Jibacoa</author><description>PCYC has continued its up-trend. It is up only about 7% &lt;g&gt; But making another 52 weeks H &lt;g&gt; bigcharts.marketwatch.com   Bernard</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27945884</link><pubDate>2/13/2012 12:26:43 PM</pubDate></item><item><title>[Jibacoa] ARRY was up 7.54% on volume  &gt; 4x its ADV. The stock started an up-trend in mid-...</title><author>Jibacoa</author><description>ARRY was up 7.54% on volume  &gt; 4x its ADV. The stock started an up-trend in mid-December and it hasn't closed the UG it had last month.&lt;g&gt; bigcharts.marketwatch.com    ARRY's  pipeline includes 4 wholly owned programs and 10 partnered programs, many of which could generate meaningful data in 2012.&lt;g&gt;  Among those is se...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27934786</link><pubDate>2/7/2012 10:17:37 PM</pubDate></item><item><title>[Jibacoa] CRIS has continued the up-trend that started in December. I was up 6.21% on volu...</title><author>Jibacoa</author><description>CRIS has continued the up-trend that started in December. I was up 6.21% on volume &gt; 3x its ADV.&lt;g&gt; Its President and CEO, Dan Passeri,  will be presenting at the 14th BIO CEO &amp; Investor Conference at 10:00 a.m. EST, next Monday, in New York City. He is expected to provide an overview of Erivedge(vismodegib), a hedgeho...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27934726</link><pubDate>2/7/2012 9:31:30 PM</pubDate></item><item><title>[Jibacoa] ARNA was up 9.09% on volume &gt; 2x its ADV, but is having some profit taking AHs.&lt;...</title><author>Jibacoa</author><description>ARNA was up 9.09% on volume &gt; 2x its ADV, but is having some profit taking AHs.&lt;g&gt; It has said that Endocrinologic Advisory Committee from the FDA has notified them of a meeting on the 2ndQ to discuss the Lorcaserin NDA resubmission. ARNA resubmitted it in Dec and the FDA has assigned a new PDUFA target of Jun27.&lt;g&gt;  b...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27931662</link><pubDate>2/6/2012 4:32:09 PM</pubDate></item><item><title>[Jibacoa] CYTX is among the  few biotechs that have doubled in price so far this year.&lt;g&gt; ...</title><author>Jibacoa</author><description>CYTX is among the  few biotechs that have doubled in price so far this year.&lt;g&gt;  It has received an IDE approval from the FDA to begin the ATHENA trial. &lt;g&gt;.  ATHENA will investigate the use of the Celution System, to prepare adipose-derived stem and regenerative cells to treat  chronic myocardial ischemia . (The IDE a...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27925416</link><pubDate>2/3/2012 11:02:52 AM</pubDate></item><item><title>[Jibacoa] &lt;&lt;MRNA 0.15 now! Are u still in? What is your new take? &gt;&gt;   Sorry for the delay...</title><author>Jibacoa</author><description>&lt;&lt;MRNA 0.15 now! Are u still in? What is your new take? &gt;&gt;   Sorry for the delayed answer. I have been bussy on other endeavours.&lt;g&gt;  But MRNA is now at $0.147 that's up &gt;5% on 361Ks.&lt;g&gt;  I have been selling it on spikes like the one on Nov29  to $0.21 with a volume of &gt; 8M  and buying back some  after the corrections....</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27819342</link><pubDate>12/12/2011 11:22:07 AM</pubDate></item><item><title>[mlkr] MRNA  0.15 now! Are u still in? What is your new take?</title><author>mlkr</author><description /><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27809909</link><pubDate>12/7/2011 11:27:29 AM</pubDate></item><item><title>[Jibacoa] MDAS is up 18.73% on volume about 5x its ADV The stock opened with a good UG, wh...</title><author>Jibacoa</author><description>MDAS is up 18.73% on volume about 5x its ADV The stock opened with a good UG, which hasn't been closed as yet.&lt;g&gt; bigcharts.marketwatch.com   The ACTAY is $14.76 MDAS  has been loosing  money and has a large LTD. The forward PE is supposedly around 11 and it has +CF of $107M and +FCF around $245M However, the insiders ...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27747131</link><pubDate>11/4/2011 2:59:13 PM</pubDate></item><item><title>[Jibacoa] ABMD is trading up 15.73% on volume &gt; half its ADV after reporting its 2ndQ resu...</title><author>Jibacoa</author><description>ABMD is trading up 15.73% on volume &gt; half its ADV after reporting its 2ndQ results this morning.&lt;g&gt; finance.yahoo.com   The ACTAY is now up to $17.79 I will still keep a TT around $20 as long as it keeps reporting good results. &lt;g&gt;  bigcharts.marketwatch.com   Bernard</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27743949</link><pubDate>11/3/2011 10:43:34 AM</pubDate></item><item><title>[Jibacoa] NBIX was up 12.61% at its intraday H and is still up 11.50% on volume of &gt; 234Ks...</title><author>Jibacoa</author><description>NBIX was up 12.61% at its intraday H and is still up 11.50% on volume of &gt; 234Ks, still below its ADV. It reported good results for its 3rdQ. &lt;g&gt; finance.yahoo.com    Will see if the stock can go through the resistance at the $7.50 level in the present market environment. &lt;g&gt; bigcharts.marketwatch.com   Bernard</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27738706</link><pubDate>11/1/2011 10:27:18 AM</pubDate></item><item><title>[Jibacoa] ILMN is up for 2nd day on a roll in spite of the general market and reporting ea...</title><author>Jibacoa</author><description>ILMN is up for 2nd day on a roll in spite of the general market and reporting earnings below expectations.&lt;g&gt; The stock was up 13.40% and is still up 9.44% It said that it plans to cut costs and that sales are expected to accelerate in the 4thQ. finance.yahoo.com   The ACTAY is $36.67 It seems that the stock could get ...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27725060</link><pubDate>10/25/2011 1:37:01 PM</pubDate></item><item><title>[Jibacoa] Hola Sergio, Nice to hear from you. I have been around SI, but you are the one t...</title><author>Jibacoa</author><description>Hola Sergio, Nice to hear from you. I have been around SI, but you are the one that had been hiding.&lt;g&gt; Also hope everything remains well.  Regarding FOLD  As you know, their main products are orally administered small molecule drugs for the treatment of various human genetic diseases.  Those drugs have been called "ch...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27658333</link><pubDate>9/24/2011 12:50:31 AM</pubDate></item><item><title>[Sergio H] Ola Bernard. Long time. Hope you are well.  FOLD  &lt;But after the presentation, t...</title><author>Sergio H</author><description>Ola Bernard. Long time. Hope you are well.  FOLD  &lt;But after the presentation, the stock did slide down.&lt;g&gt;&gt;  So, it's down some more. To a new low on really low vol. What does that spell for you, technically speaking?  Sergio</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27657552</link><pubDate>9/23/2011 3:58:21 PM</pubDate></item><item><title>[Jibacoa] FOLD was up some last week, apparently  in anticipation ofr its presentation at ...</title><author>Jibacoa</author><description>FOLD was up some last week, apparently  in anticipation ofr its presentation at UBS on Monday. But after the presentation, the stock did slide down.&lt;g&gt; However today it is among the stocks that have been able to stay on the black, albeit on low volume about 1/5 its ADV.&lt;g&gt; bigcharts.marketwatch.com   The ACTAY is $7.83...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27654930</link><pubDate>9/22/2011 3:58:58 PM</pubDate></item><item><title>[Jibacoa] PBTH is among the small group of stocks  that have managed to stay on  the black...</title><author>Jibacoa</author><description>PBTH is among the small group of stocks  that have managed to stay on  the black today.&lt;g&gt; It was up 1.0% earlier and is still up 0.499% present with volume no &gt;76.4K which is already above its ADV. bigcharts.marketwatch.com  The ACTAY is $10.67 But I would be satisfied if it can get back above the $8 level.&lt;g&gt; PBTH is...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27654803</link><pubDate>9/22/2011 3:33:40 PM</pubDate></item><item><title>[Jibacoa] In this kind of market, with the DOW down 470 points, is somewhat fun to see a b...</title><author>Jibacoa</author><description>In this kind of market, with the DOW down 470 points, is somewhat fun to see a biotech company up more than 50% on the day, albeit it is a "penny stock".&lt;g&gt;  ELGO was up 104.34% at its intraday H and is still up 53% on a volume &gt; 130Ks   It announced earlier this month  that it had completed the acquisition of  BioBala...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27654739</link><pubDate>9/22/2011 3:18:54 PM</pubDate></item><item><title>[Jibacoa] OPK is still on the black in spite of the general market.&lt;g&gt; Volume of 534.5Ks i...</title><author>Jibacoa</author><description>OPK is still on the black in spite of the general market.&lt;g&gt; Volume of 534.5Ks is still &lt; half its ADV. OPK announced today it has arranged to sell its Ophthalmic instrument division. Some OPK news.   The ACTAY is 6  bigcharts.marketwatch.com  But it would need some good news to get there in this kind of market. &lt;g&gt; Be...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27654320</link><pubDate>9/22/2011 1:27:09 PM</pubDate></item><item><title>[Jibacoa]  RE: OPK's recent news.&lt;g&gt; The news on Tuesday that OPK  had been awarded a $200...</title><author>Jibacoa</author><description> RE: OPK's recent news.&lt;g&gt; The news on Tuesday that OPK  had been awarded a $200,000 research grant from the University of Pennsylvania Center for Orphan Disease Research and Therapy to develop a therapeutic agent to treat Mucopolysaccharidoses Type I (MPS I) has to do with the technology that OPK acquired when it boug...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27624339</link><pubDate>9/8/2011 3:58:27 PM</pubDate></item><item><title>[Jibacoa] BCRX is up 15,48% on volume of 314Ks, which is already above its  ADV. bigcharts...</title><author>Jibacoa</author><description>BCRX is up 15,48% on volume of 314Ks, which is already above its  ADV. bigcharts.marketwatch.com   BCRX designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases.  It  has three  compounds in late stage development: Peramivi...</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27602520</link><pubDate>8/29/2011 3:05:26 PM</pubDate></item><item><title>[Jibacoa] AKRX opened with an UG , it was up 13.27% at its intraday H and is still up 11.7...</title><author>Jibacoa</author><description>AKRX opened with an UG , it was up 13.27% at its intraday H and is still up 11.76% on volume over 1M.&lt;g&gt;  It is presenting its 2ndQ results today and also acquiring a minority stake in Aciex.  bigcharts.marketwatch.com   Bernard</description><link>http://www.siliconinvestor.com/readmsg.aspx?msgid=27535169</link><pubDate>8/2/2011 10:28:19 AM</pubDate></item></channel></rss>